Immunovant, Inc. (IMVT) Earnings
|
Expand Research on IMVT
| Next EPS Date | 8/12/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -2.7% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +9.4% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/12/26  |
Q127 | N/A | -$0.60 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/20/26 | Q426 | -$0.73 | -$0.60 | -$0.13 | N/A | N/A | N/A |  | | Details | |
| 2/6/26 | Q326 | -$0.61 | -$0.72 | +$0.11 | N/A | N/A | N/A | | | Details | |
| 11/10/25 | Q226 | -$0.73 | -$0.71 | -$0.02 | N/A | N/A | N/A | | | Details | |
| 8/11/25 | Q126 | -$0.71 | -$0.70 | -$0.01 | N/A | N/A | N/A | | | Details | |
| 8/6/25 |
Q126 | N/A | -$0.70 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/28/25 |
Q425 | N/A | -$0.71 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 2/12/25 |
Q325 | N/A | -$0.75 | N/A | N/A | N/A | N/A | N/A | N/A |
